Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 24, 2024 | Option Exercise | $3.85 | 185,946 | 715,892 | 19,022,493 | Dec 26, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 24, 2024 | Sale | $12.00 | 185,946 | 2,231,352 | 18,836,547 | Dec 26, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 26, 2024 | Option Exercise | $3.85 | 689,495 | 2,654,556 | 19,526,042 | Dec 26, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 26, 2024 | Sale | $12.01 | 689,495 | 8,280,835 | 18,836,547 | Dec 26, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 23, 2024 | Option Exercise | $3.85 | 10,796 | 41,565 | 18,847,343 | Dec 26, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 23, 2024 | Sale | $12.00 | 10,796 | 129,552 | 18,836,547 | Dec 26, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 18, 2024 | Option Exercise | $3.85 | 412,584 | 1,588,448 | 19,249,131 | Dec 20, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 18, 2024 | Sale | $12.05 | 412,584 | 4,971,637 | 18,836,547 | Dec 20, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Dec 03, 2024 | Option Exercise | $12.20 | 3,651,985 | 44,572,477 | 18,836,547 | Dec 05, 2024, 09:00 PM | |
ROIV | Roivant Sciences Ltd. | Sukhatme Mayukh | Pres&Chief Investment Officer | Mar 30, 2024 | Option Exercise | $10.54 | 366,211 | 3,859,864 | 3,651,985 | Apr 02, 2024, 09:00 PM |